The modelling process involved sequential development, refinement, and validation of a logistic regression-based risk estimator for predicting bone metastasis in newly diagnosed prostate cancer patients using four routinely available variables: PSA, ALP, ISUP grade, and DRE-based clinical risk. This evidence concerns the gene KLK3 and bone metastasis.